Click here to download this Statement: Consensus Statement #2
Read More
NATIONAL ACADEMY OF SCIENCES STUDY OF STRATEGIES FOR KI DISTRIBUTION AND ADMINISTRATION Some time has…
ATA expresses concern to FDA regarding deletion of retitration warning after switching brands August 3,…
ATA writes letter to follow-up after FDA workshop June 30, 2005 Steven Galson, M.D. Director,…
Updated May 24, 2005 The American Thyroid Association (ATA) has developed the following response to…
Joint Public Meeting on Equivalence of Levothyroxine Sodium Products – Agenda Download Agenda (PDF File,…
ATA Public Health Committee Statement April 25, 2005 As delineated in the ATA’s prior statement…
FDA workshop on bioequivalence co-sponsored by the ATA, The Endocrine Society, and AACE [Federal Register:…
High levels of radioactive iodine exposure can cause thyroid cancer, especially in babies and children…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.